Background Cerebral venous thrombosis is a rare cause of stroke that poses diagnostic,
therapeutic, and prognostic challenges. Mainstay treatment is systemic anticoagulation, but …

Abstract Purpose of Review Cerebral venous thrombosis (CVT) is a rare cause of stroke that
most commonly affects younger women. Here, we review new literature relevant to the …

Cerebral venous thrombosis (CVT) is a rare condition accounting for< 1% of all strokes, with
highly variable clinical presentations ranging from a headache to coma. 1–4 Although MRI …

Importance To date, only uncontrolled studies have evaluated the efficacy and safety of
endovascular treatment (EVT) in patients with cerebral venous thrombosis (CVT), leading to …

Background: Anticoagulation is the mainstay treatment for cerebral venous thrombosis
(CVT). A subset of patients might deteriorate despite anticoagulation, and in such cases …

Background: Due to the rarity of cerebral venous thrombosis (CVT), performing high-quality
scientific research in this field is challenging. Providing answers to unresolved research …

Endovascular therapy of cerebral venous thrombosis using modern approaches to
intracranial recanalization, such as stent retrievers and aspiration thrombectomy, is not well …

Cerebral venous thrombosis accounts for 0.5% to 3% of all strokes. The most vulnerable
populations include young individuals, women of reproductive age, and patients with a …

BACKGROUND: Endovascular treatment (EVT) for cerebral vein thrombosis (CVT) has not
been proven to be more effective than anticoagulation based on recent results of the …

Background and purpose: 15% of cerebral venous thrombosis (CVT) patients have poor
outcomes despite anticoagulation. Uncontrolled studies suggest that endovascular …